Statement of Organization, Functions, and Delegations of Authority, 15593-15594 [2014-06019]

Agencies

• Centers for Disease Control and Prevention
• DEPARTMENT OF HEALTH AND HUMAN SERVICES

[Federal Register Volume 79, Number 54 (Thursday, March 20, 2014)]
[Notices]
[Pages 15593-15594]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-06019]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Statement of Organization, Functions, and Delegations of 
Authority

    Part C (Centers for Disease Control and Prevention) of the 
Statement of Organization, Functions, and Delegations of Authority of 
the Department of Health and Human Services (45 FR 67772-76, dated 
October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as 
amended most recently at 78 FR 79697-79699, dated December 31, 2013) is 
amended to reflect the reorganization of the Division of Diabetes 
Translation, National Center for Chronic Disease Prevention and Health 
Promotion, Centers for Disease Control and Prevention.
    Section C-B, Organization and Functions, is hereby amended as 
follows:
    Delete in its entirety the title and the mission and function 
statements for the Division of Diabetes Translation (CUCG) and insert 
the following:
    Division of Diabetes Translation (CUCG). In collaboration with 
NCCDPHP divisions, other CDC components, other HHS agencies, state, 
tribal, local and territorial government agencies, academic 
institutions, and voluntary and private sector organizations, the 
Division of Diabetes Translation; (1) plans, directs, and coordinates a 
national program to prevent diabetes and reduce morbidity, mortality, 
disability, and cost associated with diabetes and its complications; 
(2) identifies, evaluates, and implements programs and policies to 
prevent and control diabetes through the translation of evidence-based 
models and interventions for improved health care and self-care 
practices into widespread clinical and community practice; (3) conducts 
surveillance of diabetes, its complications, and the utilization of 
health care and prevention resources to monitor trends and evaluate 
program impact on morbidity, mortality, disability, and cost; (4) 
conducts epidemiologic studies and disseminates finding to identify and 
evaluate the feasibility and effectiveness of potential prevention and 
control strategies at the community level; (5) develops or supports 
clinical and public health guidelines and strategies to form the basis 
for community interventions; and (6) provides technical consultation 
and assistance to national, state and local organizations to implement 
and evaluate cost effective interventions to reduce morbidity, 
mortality, and disability.
    Office of the Director (CUCG1). (1) Establishes and interprets 
policies and determines program priorities; (2) provides leadership and 
guidance in strategic planning, budget formulation, programmatic and 
scientific planning, development, and management, administrative 
management and operations of the division; (3) coordinates the 
monitoring and reporting of division priorities, accomplishments, 
future directions, and resource requirements; (4) leads and coordinates 
policy, communications and partnership activities; and (5) coordinates 
division activities with other components of NCCDPHP and CDC, 
organizations in the public and private sectors, and other federal 
agencies.
    Epidemiology and Statistics Branch (CUCGB). (1) Conducts national 
surveillance of diabetes and its complications, including surveillance 
of the degree of diffusion and dissemination of preventive services and 
the utilization of health care; (2) identifies clinical, health 
services, and public health research findings and technologies that 
have potential to prevent or control diabetes and its complications 
through public health avenues; (3) develops and analyzes mathematical 
and economic models to project the burden of diabetes and prioritize 
effective interventions to prevent and control diabetes; (4) conducts 
epidemiologic studies to identify high-risk population groups and other 
risk factors for diabetes and its complications; (5) conducts cost and 
cost-effectiveness analyses of diabetes prevention and control to 
prioritize strategies for policy-makers; (6) provides scientific and 
technical support to division staff, state and local health agencies, 
and others in planning and implementation of surveillance and 
effectiveness studies to reduce morbidity and mortality from diabetes; 
and (7) collaborates with counterparts in other divisions, academic 
institutions, and other HHS agencies by conducting national public 
health research projects and by providing technical assistance in areas 
of epidemiology, surveillance, and economics.
    Program Implementation Branch (CUCGC). (1) Provides programmatic 
leadership, guidance and consultation on a range of strategies to 
improve diabetes prevention and control programs in states, 
territories, tribes, and local jurisdictions; (2) identifies, develops, 
implements and evaluates strategies to prevent and control diabetes 
through widespread community practice and through the application of 
policy and environmental interventions, health systems interventions 
and community interventions; (3) provides leadership, management and 
oversight for the National Diabetes Prevention Program; (4) develops, 
implements and supports work with vulnerable and disparate population 
groups and (5) coordinates and collaborates with counterparts in other 
divisions, HHS agencies, academic institutions, and national and 
voluntary organizations to improve public health diabetes prevention 
and control programs, practices and policies.
    Translation, Health Education, and Evaluation Branch (CUCGD). (1) 
Synthesizes and translates a body of best science and practice that can 
be applied to various public health settings; (2) Analyzes, 
disseminates, and publishes data from diabetes prevention and control 
programs to develop operational strategies for translation of results 
into improved practice; (3) prepares and disseminates products that 
translate applied research, program evaluation, and health economics 
science to state programs and others; (4) provides technical assistance 
and implementation support for evidence-based and practice-based 
communication strategies, including web management, that advance 
diabetes prevention and control; (5) designs, evaluates and implements 
national education strategies directed toward health care professionals 
and systems, individuals with and at risk for diabetes, community 
leaders, business, and general public; (6) evaluates program policies, 
plans, procedures, priorities,

[[Page 15594]]

and guidelines being implemented in the field to improve health, 
prevent or delay type 2 diabetes and reduce morbidity, mortality, 
disability and costs associated with diabetes and its complications; 
and (7) provides evaluation support for division programs, grants, and 
policies, including the design and evaluation of data collection 
instruments for evaluation of programs.

    Dated: March 12, 2014.
Sherri A. Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2014-06019 Filed 3-19-14; 8:45 am]
BILLING CODE 4160-18-M